Seres Therapeutics Inc (NASDAQ:MCRB) has a beta value of 1.96 and has seen 11.88 million shares traded in the last trading session. The company, currently valued at $109.62M, closed the last trade at $0.72 per share which meant it lost -$0.07 on the day or -7.80% during that session. The MCRB stock price is -634.72% off its 52-week high price of $5.29 and 25.0% above the 52-week low of $0.54. The 3-month trading volume is 4.73 million shares.
Seres Therapeutics Inc (NASDAQ:MCRB) trade information
Sporting -7.80% in the red in last session, the stock has traded in the red over the last five days, when the MCRB stock price touched $0.72 or saw a rise of 11.44%. Year-to-date, Seres Therapeutics Inc shares have moved -48.30%, while the 5-day performance has seen it change -6.71%. Over the past 30 days, the shares of Seres Therapeutics Inc (NASDAQ:MCRB) have changed -21.47%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Seres Therapeutics Inc (MCRB) estimates and forecasts
Figures show that Seres Therapeutics Inc shares have underperformed across the wider relevant industry. The company’s shares have lost -48.67% over the past 6 months, with this year growth rate of -15.73%, compared to 15.50% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 18.22% over the past 5 years.
MCRB Dividends
Seres Therapeutics Inc is expected to release its next earnings report in August this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
